Evidence map›Paper›PMID 21750396›Full record

ReviewJournal of endocrinological investigation2011

Diagnosis and treatment of autoimmune hypophysitis: a short review.

I Lupi, L Manetti, V Raffaelli, M Lombardi, M Cosottini, A Iannelli, F Basolo, A Proietti, F Bogazzi, P Caturegli and 1 more

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Journal of endocrinological investigation, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Hypophysitis, the Growing Spectrum of a Rare Pituitary Disease.The Journal of clinical endocrinology and metabolism · 2022
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Inflammatory Disorders of the Skull Base: a Review.Current neurology and neuroscience reports · 2019
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Hypophysitis: Evaluation and Management.Clinical diabetes and endocrinology · 2016
    Review
  18. Article
  19. Article
  20. Update on hypophysitis and TTF-1 expressing sellar region masses.Brain pathology (Zurich, Switzerland) · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

I LupiDepartment of Endocrinology and Metabolism, University of Pisa, Ospedale Cisanello, via Paradisa, 2 56124 Pisa, Italy. isabellalupi@yahoo.it
L Manetti
V Raffaelli
M Lombardi
M Cosottini
A Iannelli
F Basolo
A Proietti
F Bogazzi
P Caturegli
E Martino
University of Pisa · ITOspedale Cisanello · ITJohns Hopkins Medicine · US

Funding

A new serum test for the differential diagnosis of pituitary massesR21DK080351 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI CATUREGLI, PATRIZIO · 2009 to 2010
$490k
NIDDK NIH HHS DK080351
6 · The paper itself

Abstract

Medical therapy of autoimmune hypophysitis with immunosuppressive drugs can be effective to induce remission of the disease by treating both pituitary dysfunction and compression symptoms. We describe the case of a 41-yr-old man with autoimmune hypophysitis in whom prednisone therapy induced remission of the disease but was followed by a sudden relapse after withdrawal. A second trial of corticosteroid was started and succeeded in inducing remission of the disease. Eight months after the second withdrawal pituitary function was restored, pituitary mass had disappeared, only partial diabetes insipidus remained unchanged. Review of the literature identified 30 articles, among case reports and case series, reporting a total of 44 cases of autoimmune hypophysitis treated with glucocorticoids and/or azathioprine. Combining all the cases, medical therapy resulted to be effective in reducing the pituitary mass in 84%, in improving anterior pituitary function in 45%, and in restoring posterior pituitary function in 41%. Clinical aspects of autoimmune hypophysitis are discussed and a possible algorithm for the diagnosis and treatment of the disease is proposed.

Indexed as

AdultAutoimmune DiseasesGlucocorticoidsHumansMagnetic Resonance ImagingMalePituitary DiseasesPrednisoneRecurrenceRemission InductionGlucocorticoidsPrednisone

Identifiers

PMID21750396
OpenAlexW151697276

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.